SOLCF - SOL Global Investments Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
2.9626
+0.2226 (+8.12%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.7400
Open2.8500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.8200 - 3.1000
52 Week Range0.7000 - 4.9800
Volume183,938
Avg. Volume65,423
Market Cap140.302M
Beta (3Y Monthly)N/A
PE Ratio (TTM)0.73
EPS (TTM)4.0340
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire8 days ago

    Ready for 2019?....Hemp Yeah!: New Hemp Harvest and Extraction Agreements for 2019 and Beyond

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the new extraction and cultivation agreements in the works in preparation for the burgeoning hemp/CBD industry. At the start of the month, Tilray, Inc. (NASDAQ: TLRY) reported the closing of a previously announced definitive agreement in which Tilray had acquired all of the issued and outstanding securities of FHF Holdings Ltd. from Compass Group Diversified Holdings, LLC and other shareholders of Manitoba Harvest. Tilray acquired Manitoba Harvest on a cash and debt-free basis, for an aggregate maximum purchase price of C$419 million, pending the achievement of certain milestones after the closing of the Transaction.

  • GlobeNewswire8 days ago

    THC to CBD: More Cannabis Companies Expand Their CBD Capabilities

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing number of cannabis companies expanding their CBD capabilities, following the major market trends for 2019. Every company and investor in the cannabis industry is well aware of the hype surrounding the potential for CBD and hemp. The momentum of CBD is making everyone take notice and many cannabis companies are not wasting this momentum for CBD, investing in new partnerships and business changes to ensure a strong position for the future.

  • MarketWatch8 days ago

    Cannabis retailer Harvest Health makes $850 million all-stock acquisition

    Harvest Health and Recreation Inc. said Monday that it plans to buy rival cannabis company Verano Holdings LLC for $850 million in stock. Harvest Health trades on the Canadian Securities Exchange and over the counter in the U.S. and went public in November on the CSE. Harvest Health's over the counter stock surged more than 12% in Monday trading. In a press release, Harvest Health said the acquisition cost was based on its share price of $C8.79 ($6.55) and that upon completion the deal it would operate 30 retail stores, eight grow sites and seven manufacturing facilities. Harvest Health has aggressive growth plans and said in the release by the end of 2019, it will have 70 shops, 13 pot farms and 13 manufacturing facilities. Sol Global Investments Corp. has a 15% stake in Verano, which Sol says is worth $127.5 million. Sol Global's chief investment officer and chairman of the board is Andy DeFrancesco, who short sellers Hindenburg Research and Quintessential Capital Management allege was involved with a pump and dump scheme related to Canada-based Aphria Inc.

  • SOL Global Announces Receipt of Approval for Sale and Transfer of Florida 3 Boys Farms Operations and Assets
    PR Newswire9 days ago

    SOL Global Announces Receipt of Approval for Sale and Transfer of Florida 3 Boys Farms Operations and Assets

    TORONTO, March 11, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (Frankfurt: 9SB) is excited to announce that the Company has received approval from the Florida Department of Health for the sale and transfer of the 3 Boys Farm ("3 Boys") license from CannCure Investments Inc. ("CannCure") to SOL Global. The approval includes the transfer of all operations and assets, including farms and dispensaries.

  • SOL Global Subsidiary Heavenly Rx Announces Acquisition of 568 Acres of Hemp Farms for Biomass Production
    PR Newswire12 days ago

    SOL Global Subsidiary Heavenly Rx Announces Acquisition of 568 Acres of Hemp Farms for Biomass Production

    TORONTO, March 7, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (Frankfurt: 9SB) is pleased to announce that it has signed a binding letter of intent ("LOI") to acquire three tracts of agricultural property totaling 568 acres of land in the States of Tennessee and Kentucky for the cultivation and production of raw hemp biomass. The Company will assign the agricultural property to its hemp/CBD-focused subsidiary, Heavenly Rx Ltd. ("Heavenly").

  • GlobeNewswire15 days ago

    CBD Is Going to The Dogs: Continued Growth in Hemp Derived Pet Products

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at continued growth in the CBD pet industry and potential movers in the space. Canopy Growth Corporation (TSX: WEED.TO) (NYSE: CGC), always a strong market indicator, partnered with Sequential Brands Group, Inc. to announce that Martha Stewart has joined the Company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories, one of which is the rapidly growing pet wellness category.

  • PR Newswire15 days ago

    SOL Global Provides Update on Groundbreaking Achievement Made by Its European Strategic Investment European Cannabis Holdings

    TORONTO, March 4, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (Frankfurt: 9SB) is pleased to provide an update on the operations of one of its significant international investments, European Cannabis Holdings ("ECH"). In February 2019, ECH celebrated a historic milestone by becoming the first company in the United Kingdom to facilitate the importation of a bulk shipment of medical cannabis.

  • PR Newswire18 days ago

    SOL Global Announces Results for the Three and Nine-Month Period Ended December 31, 2018

    TORONTO, March 1, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (Frankfurt: 9SB) is pleased to release its financial results for the three and nine months ended December 31, 2018, and provide a general corporate update, including a management-prepared internal net asset value calculation. The Company's unaudited condensed interim consolidated financial statements and Management's Discussion and Analysis (the "MD&A") for the three and nine months ended December 31, 2018 are also provided herein.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. "Sunday, March 3 will mark four months since I was appointed as CEO of SOL Global.

  • SOL Global Announces Completion of Investment in European Cannabis Holdings
    CNW Group20 days ago

    SOL Global Announces Completion of Investment in European Cannabis Holdings

    TORONTO , Feb. 27, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (9SB.F) is pleased to announce the close of its latest investment in European Cannabis Holdings ("ECH"), a group of companies helping to shape the future of cannabis in Europe .

  • SOL Global Announces Formation of International Hemp Company Heavenly Rx
    CNW Group23 days ago

    SOL Global Announces Formation of International Hemp Company Heavenly Rx

    TORONTO , Feb. 25, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL) (SOLCF) (9SB.F) is pleased to announce the formation of a new international hemp-focused subsidiary, Heavenly Rx Ltd. ("Heavenly Rx"). Heavenly Rx intends to hold controlling ownership interests in various industry-leading assets in the hemp/CBD and THC-free cannabinoid wellness space, with an initial focus on hemp cultivation, processing and the manufacturing of a diverse range of traditional CBD products including oils, tinctures, balms, and vape-ready products. Additionally, Heavenly Rx intends to include several proprietary brands across numerous consumer product group verticals such as cosmetics and beauty products, bath and body products, infused foods (subject to governmental approvals and/or compliance) and a number of pet-related products.

  • Benzinga2 months ago

    Q&A: SOL Global's CEO Brady Cobb Chats About The Brave New World Of Cannabis Investing

    Canada legalized cannabis for recreational use back in October and, with the passage of the 2018 Farm Bill in December, the narrative around hemp farming and the cannabis industry as a whole has pivoted. The growing international acceptance of medicinal cannabis is opening the door for investment firms and venture capitalists to explore new partnerships, groundbreaking products and untapped global markets at a pace never before seen. You’re working with the University of Miami on how cannabis can help those affected by concussions in sports.

  • CNW Group2 months ago

    SOL Global Investments Announces Voting Results from the Annual and Special Meeting of Shareholders

    The approval of the change of business of the Company from a "life sciences issuer" to an "investment company" as those terms are used in the policies of the Canadian Securities Exchange with over 99% of the shares represented at the meeting, representing both a simple majority and a majority excluding the shares of the insiders of the Company, voting in favour.

  • PR Newswire2 months ago

    SOL Global Announces Completion of Normal Course Issuer Bid for Purchase of 5% of Company's Common Shares

    TORONTO, Jan. 8, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (Frankfurt: 9SB) is pleased to announce the completion of its normal course issuer bid ("NCIB") for the purchase of 2,451,861 of the Company's common shares, representing approximately 5% of its issued and outstanding common shares at the time of the commencement of the NCIB. The shares were purchased through the facilities of the Canadian Securities Exchange at an average purchase price of $2.00 per share.

  • PR Newswire2 months ago

    SOL Global Announces Investment in and Strategic Partnership with European Medical Cannabis and CBD Firm GreenLight Pharmaceuticals Ltd.

    TORONTO, Jan. 2, 2018 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (Frankfurt: 9SB) (SOLCF) is pleased to announce an investment in and strategic partnership with European medical cannabis company, GreenLight Pharmaceuticals Ltd. ("GreenLight Pharmaceuticals" or "GreenLight"). GreenLight, which was founded in 2014 and is headquartered in Dublin, Ireland, is a vertically-integrated medical cannabis company with a clinical research and development operation led by Dr. James Linden, a seed genetics program, cultivation operations, and CBD brand and distribution operations.

  • Apple plans to build a $1B campus in Austin, Texas
    Yahoo Finance3 months ago

    Apple plans to build a $1B campus in Austin, Texas

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:00 a.m. ET.

  • Congress passing $867B farm bill is ‘a big moment for the American cannabis movement’
    Yahoo Finance Video3 months ago

    Congress passing $867B farm bill is ‘a big moment for the American cannabis movement’

    Congress has voted to pass an $867 billion farm bill, which will in part lift restrictions on hemp, a market that could become a $20 billion industry. Yahoo Finance’s Alexis Christoforous speaks to SOL Global Investments CEO Brady Cobb.